In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

AUTOR(ES)

Alvarez, S

RESUMO

We tested 53 clinical isolates of Branhamella catarrhalis recovered from patients with respiratory symptoms to determine the susceptibility of the isolates to 25 antimicrobial agents, including the newer beta-lactam antibiotics. Of the 53 strains, 46 (86.7%) were beta-lactamase producers. All the strains were susceptible to the majority of the new penicillins and cephalosporins. The combinations of amoxacillin-clavulanic acid and ticarcillin-clavulanic acid were also very active against the beta-lactamase-producing strains.

Documentos Relacionados

• Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.
• Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays.
• Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
• Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.
• Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.